Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00386958 · ClinicalTrials.gov registry record · Phase 2
A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers
A Phase 2 study, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 172
- Enrollment target
NCT00386958 is a Phase 2 study that has completed, run by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center. The registered enrollment target is 172 participants.
The verdict
NCT00386958, a Phase 2 study, has completed, sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 172 participants
- Enrollment target
Study Summary
Bacterial corneal ulcers are a leading cause of pediatric blindness in underdeveloped countries due to a lack of antibiotic availability and affordability, among other reasons. Povidone-iodine, an inexpensive and readily available broad-spectrum antimicrobial agent, may be an effective and affordable treatment for corneal ulcers, allowing preservation of sight for those afflicted with this disease.
Interventions
- DRUG Povidone-Iodine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2002-11 |
| Est. Completion | 2006-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00386958
The ClinicalTrials.gov registry entry for NCT00386958 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 172 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Povidone-Iodine is the first listed.
NCT00386958 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00386958 about?
NCT00386958 is a clinical study titled "A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers". Bacterial corneal ulcers are a leading cause of pediatric blindness in underdeveloped countries due to a lack of antibiotic availability and affordability, among other reasons. Povidone-iodine, an inexpensive and readily available broad-spectrum antimicrobial agent, may be an effective and affordabl...
What is the current status of trial NCT00386958?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 172 participants. The study started on 2002-11. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00386958?
The interventions under investigation include: Povidone-Iodine (DRUG).
Who is sponsoring clinical trial NCT00386958?
This trial is sponsored by Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.